186 related articles for article (PubMed ID: 32350715)
1. ASO Author Reflections: Preoperative Nomogram Identifies Patients for Selective Omission of SLNB in Breast Cancer-to Promote Implementation of the Choosing Wisely Campaign Recommendations.
Tran HT; Jackson RS
Ann Surg Oncol; 2020 Aug; 27(8):2687-2688. PubMed ID: 32350715
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.
Okuno J; Miyake T; Shimazu K; Noguchi S
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):810-811. PubMed ID: 32632881
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.
Castelo M; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2677-2678. PubMed ID: 32206953
[No Abstract] [Full Text] [Related]
4. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
Vicini E; Fontana SKR; Leonardi MC; Veronesi P; Galimberti V
Ann Surg Oncol; 2022 Mar; 29(3):1761-1762. PubMed ID: 34757548
[No Abstract] [Full Text] [Related]
6. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
[TBL] [Abstract][Full Text] [Related]
7. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
Mamtani A; Morrow M
Ann Surg Oncol; 2020 Oct; 27(10):3593-3594. PubMed ID: 32440719
[No Abstract] [Full Text] [Related]
8. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
Lambert LA; Ayers GD; Meric-Bernstam F
Ann Surg Oncol; 2007 Aug; 14(8):2422-3. PubMed ID: 17514406
[No Abstract] [Full Text] [Related]
9. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-Based Nomogram Identifies Breast Cancer Patients Unlikely to Harbor Axillary Metastasis: Towards Selective Omission of Sentinel Lymph Node Biopsy.
Tran HT; Pack D; Mylander C; Martino L; Rosman M; Tafra L; Jackson RS
Ann Surg Oncol; 2020 Aug; 27(8):2679-2686. PubMed ID: 32026063
[TBL] [Abstract][Full Text] [Related]
11. High Compliance With Choosing Wisely Breast Surgical Guidelines at a Safety-Net Hospital.
Tang A; Mooney CM; Mittal A; Dzubnar JM; Knopf KB; Khoury AL
J Surg Res; 2022 Apr; 272():96-104. PubMed ID: 34953372
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy indications and controversies in breast cancer.
Wiatrek R; Kruper L
Maturitas; 2011 May; 69(1):7-10. PubMed ID: 21411254
[TBL] [Abstract][Full Text] [Related]
13. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
14. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
15. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
[TBL] [Abstract][Full Text] [Related]
16. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
Dihge L; Bendahl PO; Rydén L
Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
[TBL] [Abstract][Full Text] [Related]
17. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
18. A head to head comparison of nine tools predicting non-sentinel lymph node status in sentinel node positive breast cancer women.
van den Hoven I; Kuijt G; Roumen R; Voogd A; Steyerberg EW; Vergouwe Y
J Surg Oncol; 2015 Aug; 112(2):133-8. PubMed ID: 26258749
[TBL] [Abstract][Full Text] [Related]
19. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
[TBL] [Abstract][Full Text] [Related]
20. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up.
Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH
Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
